Suppr超能文献

24 只猫中行术中超声引导下皮下输尿管旁路装置放置术,联合或不联合显微外科输尿管切开术。

Subcutaneous ureteral bypass device placement with intraoperative ultrasound guidance, with or without microsurgical ureterotomy, in 24 cats.

机构信息

Department of Clinical Sciences, Small Animal Internal Medicine, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA, USA.

出版信息

J Feline Med Surg. 2021 Dec;23(12):1183-1191. doi: 10.1177/1098612X211002014. Epub 2021 Mar 23.

Abstract

OBJECTIVES

The aim of this study was to describe a method of subcutaneous ureteral bypass (SUB) device placement with intraoperative ultrasound guidance, with or without microsurgical ureterotomy, for the treatment of benign ureteral obstruction(s) in cats. A secondary aim was to describe the complications and outcomes in our population, and compare the two groups with and without ureterotomy.

METHODS

The medical records of cats with benign ureteral obstruction(s) treated with SUB device placement with intraoperative ultrasound guidance between April 2013 and June 2018 were reviewed.

RESULTS

Twenty-four cats with 30 obstructed ureters had a SUB device placement with intraoperative ultrasound guidance in 26 surgeries. A microsurgical ureterotomy was performed in 14/26 surgeries. Median age was 10.07 years (range 4-16.6). Eleven of 24 cats (46%) had a previous history of chronic kidney disease (CKD). All cats, including two patients with minimal pelvic dilation (⩽4 mm), had a successful intrapelvic placement of the SUB device. Median survival time was 1555 days (4.25 years); this was not significantly different between the two groups ( = 0.4494). Stone analysis and bacterial culture, where available for review, revealed calcium oxalate in 12/12 and a negative culture in 6/7. The ureterotomy significantly prolonged the procedure duration (180 vs 125 mins) without significantly decreasing the short- and long-term complications ( = 0.1588 and  = 0.2921, respectively), or the survival time ( = 0.8437).

CONCLUSIONS AND RELEVANCE

SUB device placement with intraoperative ultrasound guidance is an effective alternative for the treatment of ureteral obstruction. Ultrasound guidance may be a more accessible option when a trained veterinarian does not have access to fluoroscopy. Microsurgical ureterotomy did not show any advantage and prolonged the anesthesia. Our median survival time emphasizes a good outcome of SUB device placement, even in cats with a previous history of CKD.

摘要

目的

本研究旨在描述一种在术中超声引导下进行皮下输尿管旁路(SUB)装置放置的方法,包括或不包括显微输尿管切开术,用于治疗猫的良性输尿管梗阻。次要目的是描述我们人群中的并发症和结果,并比较有和没有输尿管切开术的两组。

方法

回顾了 2013 年 4 月至 2018 年 6 月期间接受术中超声引导下 SUB 装置放置治疗良性输尿管梗阻的猫的病历。

结果

26 例手术中有 24 只猫的 30 条梗阻输尿管进行了 SUB 装置放置,其中 14 例进行了显微输尿管切开术。中位年龄为 10.07 岁(范围 4-16.6)。24 只猫中有 11 只(46%)有慢性肾病(CKD)的既往病史。所有猫,包括 2 只骨盆扩张最小(⩽4 mm)的猫,均成功地将 SUB 装置置于盆腔内。中位生存时间为 1555 天(4.25 年);两组之间无显著差异( = 0.4494)。结石分析和细菌培养的结果显示,12/12 例为草酸钙,7/6 例为阴性培养。输尿管切开术显著延长了手术时间(180 分钟对 125 分钟),但并没有显著降低短期和长期并发症( = 0.1588 和  = 0.2921)或生存时间( = 0.8437)。

结论和相关性

在术中超声引导下进行 SUB 装置放置是治疗输尿管梗阻的一种有效替代方法。当有训练的兽医无法获得透视时,超声引导可能是一种更易获得的选择。显微输尿管切开术没有显示出任何优势,反而延长了麻醉时间。我们的中位生存时间强调了 SUB 装置放置的良好结果,即使在有 CKD 既往病史的猫中也是如此。

相似文献

1
Subcutaneous ureteral bypass device placement with intraoperative ultrasound guidance, with or without microsurgical ureterotomy, in 24 cats.
J Feline Med Surg. 2021 Dec;23(12):1183-1191. doi: 10.1177/1098612X211002014. Epub 2021 Mar 23.
2
Placement of subcutaneous ureteral bypasses without fluoroscopic guidance in cats with ureteral obstruction: 19 cases (2014-2016).
J Feline Med Surg. 2017 Oct;19(10):1030-1039. doi: 10.1177/1098612X16670572. Epub 2016 Sep 30.
5
Subcutaneous ureteral bypass device placement in 81 cats with benign ureteral obstruction (2013-2018).
J Vet Intern Med. 2021 Nov;35(6):2778-2786. doi: 10.1111/jvim.16280. Epub 2021 Dec 10.
7
Clinical presentation and outcome of cats with circumcaval ureters associated with a ureteral obstruction.
J Vet Intern Med. 2015 Jan;29(1):63-70. doi: 10.1111/jvim.12465. Epub 2014 Sep 30.
8
A retrospective study of anesthesia for subcutaneous ureteral bypass placement in cats: 27 cases.
J Vet Med Sci. 2017 Jun 10;79(6):992-998. doi: 10.1292/jvms.16-0382. Epub 2017 Apr 20.
9
Complications and survival after subcutaneous ureteral bypass device placement in 24 cats: a retrospective study (2016-2019).
J Feline Med Surg. 2021 Aug;23(8):759-769. doi: 10.1177/1098612X20975374. Epub 2020 Nov 24.

引用本文的文献

本文引用的文献

1
Medical and Interventional Management of Upper Urinary Tract Uroliths.
Vet Clin North Am Small Anim Pract. 2019 Mar;49(2):157-174. doi: 10.1016/j.cvsm.2018.11.004.
3
Ultrasonography in the diagnosis and management of cats with ureteral obstruction.
J Feline Med Surg. 2018 Jan;20(1):15-22. doi: 10.1177/1098612X17694253. Epub 2017 Feb 1.
5
Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.
Urolithiasis. 2017 Aug;45(4):329-336. doi: 10.1007/s00240-017-0978-x. Epub 2017 Mar 30.
6
Outcome in cats with benign ureteral obstructions treated by means of ureteral stenting versus ureterotomy.
J Am Vet Med Assoc. 2016 Dec 1;249(11):1292-1300. doi: 10.2460/javma.249.11.1292.
7
Placement of subcutaneous ureteral bypasses without fluoroscopic guidance in cats with ureteral obstruction: 19 cases (2014-2016).
J Feline Med Surg. 2017 Oct;19(10):1030-1039. doi: 10.1177/1098612X16670572. Epub 2016 Sep 30.
8
ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats.
J Vet Intern Med. 2016 Sep;30(5):1564-1574. doi: 10.1111/jvim.14559. Epub 2016 Sep 9.
10
Outcomes of ureteral surgery and ureteral stenting in cats: 117 cases (2006-2014).
J Am Vet Med Assoc. 2016 Mar 1;248(5):518-25. doi: 10.2460/javma.248.5.518.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验